GlaxoSmithKline Pharmaceuticals Limited announced appointment of Mr. Juby Chandy as Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,539 INR | +0.53% |
|
-4.71% | +33.80% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.80% | 5.15B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as Chief Financial Officer